Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T15:46:05.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:44:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, with the displayed site revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:50:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:10:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a basic HTML header and a Home link, along with a revision note indicating version 3.7.0, signaling an access-restriction state rather than updates to study content.
    Difference
    18%
    Check dated 2026-09-21T22:12:30.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6. This indicates a new version of the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:10:56.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.